TY - JOUR
T1 - Who uses a prescription drug monitoring program and how? Insights from a statewide survey of oregon clinicians
AU - Irvine, Jessica M.
AU - Hallvik, Sara E.
AU - Hildebran, Christi
AU - Marino, Miguel
AU - Beran, Todd
AU - Deyo, Richard (Rick)
N1 - Funding Information:
Supported by the National Institutes of Health , National Institute on Drug Abuse through Grant # 1 R01 DA031208-01A1 and by the National Center for Research Resources and the National Center for Advancing Translational Sciences , through grant UL1RR024140 .
PY - 2014/7
Y1 - 2014/7
N2 - Prescription drug monitoring programs (PDMPs) are relatively new but potentially useful tools to enhance prudent prescribing of controlled substances. However, little is known about the types of clinicians who make the most use of PDMPs, how these programs are incorporated into clinicians' work flow, or how clinicians and patients respond to the information. We therefore surveyed a random sample of Oregon providers, with 1,065 respondents. Clinicians in emergency medicine, primary care, and pain and addiction specialties were the largest number of registrants, but many frequent prescribers of controlled substances were not registered to use the PDMP. Among users, 95% reported accessing the PDMP when they suspected a patient of abuse or diversion, but fewer than half would check it for every new patient or every time they prescribe a controlled drug. Nearly all PDMP users reported that they discuss worrisome PDMP data with patients; 54% reported making mental health or substance abuse referrals, and 36% reported sometimes discharging patients from the practice. Clinicians reported frequent patient denial or anger and only occasional requests for help with drug dependence. More research is needed to optimize how clinicians use PDMPs across settings and how clinicians and patients respond to the data. Perspective This study examined differences between PDMP users and nonusers and how clinicians in various specialties use PDMPs in practice. A better understanding of effective PDMP use will facilitate access to treatment for patients with pain while curbing the prescription drug epidemic and may ultimately reduce abuse, misuse, and overdose death.
AB - Prescription drug monitoring programs (PDMPs) are relatively new but potentially useful tools to enhance prudent prescribing of controlled substances. However, little is known about the types of clinicians who make the most use of PDMPs, how these programs are incorporated into clinicians' work flow, or how clinicians and patients respond to the information. We therefore surveyed a random sample of Oregon providers, with 1,065 respondents. Clinicians in emergency medicine, primary care, and pain and addiction specialties were the largest number of registrants, but many frequent prescribers of controlled substances were not registered to use the PDMP. Among users, 95% reported accessing the PDMP when they suspected a patient of abuse or diversion, but fewer than half would check it for every new patient or every time they prescribe a controlled drug. Nearly all PDMP users reported that they discuss worrisome PDMP data with patients; 54% reported making mental health or substance abuse referrals, and 36% reported sometimes discharging patients from the practice. Clinicians reported frequent patient denial or anger and only occasional requests for help with drug dependence. More research is needed to optimize how clinicians use PDMPs across settings and how clinicians and patients respond to the data. Perspective This study examined differences between PDMP users and nonusers and how clinicians in various specialties use PDMPs in practice. A better understanding of effective PDMP use will facilitate access to treatment for patients with pain while curbing the prescription drug epidemic and may ultimately reduce abuse, misuse, and overdose death.
KW - Prescription drug monitoring program
KW - controlled substances
KW - opioid prescribing
KW - prescription drug abuse
KW - survey
UR - http://www.scopus.com/inward/record.url?scp=84903552423&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84903552423&partnerID=8YFLogxK
U2 - 10.1016/j.jpain.2014.04.003
DO - 10.1016/j.jpain.2014.04.003
M3 - Article
C2 - 24787089
AN - SCOPUS:84903552423
SN - 1526-5900
VL - 15
SP - 747
EP - 755
JO - Journal of Pain
JF - Journal of Pain
IS - 7
ER -